Jim Simons Next Cure, Inc. Transaction History

Renaissance Technologies LLC

$62.3 Billion
Q1 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Next Cure, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 479,962 shares of NXTC stock, worth $235,181. This represents 0.0% of its overall portfolio holdings.

Number of Shares

479,962

Previous 519,300 7.58%

Holding current value

$235,181

Previous $399,000 42.36%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$0.48 - $0.95 $18,882 - $37,371	-39,338 Reduced 7.58%	479,962 $230,000
Q4 2024 Feb 13, 2025	BUY	$0.77 - $1.54 $87,241 - $174,482	113,300 Added 27.91%	519,300 $399,000
Q3 2024 Nov 13, 2024	SELL	$1.33 - $1.78 $74,671 - $99,936	-56,144 Reduced 12.15%	406,000 $556,000
Q2 2024 Aug 09, 2024	BUY	$1.17 - $2.49 $72,240 - $153,742	61,744 Added 15.42%	462,144 $734,000
Q1 2024 May 13, 2024	BUY	$1.13 - $2.23 $121,006 - $238,799	107,085 Added 36.51%	400,400 $893,000
Q4 2023 Feb 13, 2024	BUY	$1.03 - $1.45 $44,408 - $62,516	43,115 Added 17.23%	293,315 $334,000
Q3 2023 Nov 14, 2023	BUY	$1.29 - $1.84 $3,870 - $5,520	3,000 Added 1.21%	250,200 $323,000
Q2 2023 Aug 11, 2023	BUY	$1.47 - $1.86 $3,969 - $5,022	2,700 Added 1.1%	247,200 $445,000
Q1 2023 May 12, 2023	SELL	$1.46 - $1.83 $236,644 - $296,615	-162,085 Reduced 39.86%	244,500 $362,000
Q4 2022 Feb 13, 2023	BUY	$1.2 - $3.07 $211,902 - $542,115	176,585 Added 76.78%	406,585 $573,000
Q3 2022 Nov 14, 2022	SELL	$2.72 - $5.19 $167,943 - $320,451	-61,744 Reduced 21.16%	230,000 $633,000
Q2 2022 Aug 12, 2022	BUY	$3.38 - $5.27 $483,150 - $753,314	142,944 Added 96.06%	291,744 $1.37 Million
Q1 2022 May 13, 2022	BUY	$4.76 - $6.24 $186,592 - $244,608	39,200 Added 35.77%	148,800 $723,000
Q4 2021 Feb 11, 2022	SELL	$5.7 - $9.1 $1.51 Million - $2.41 Million	-264,500 Reduced 70.7%	109,600 $658,000
Q3 2021 Nov 12, 2021	BUY	$6.74 - $8.02 $1.17 Million - $1.39 Million	173,800 Added 86.77%	374,100 $2.52 Million
Q2 2021 Aug 13, 2021	BUY	$7.6 - $10.28 $1.52 Million - $2.06 Million	200,300 New	200,300 $1.61 Million
Q3 2020 Nov 13, 2020	SELL	$8.15 - $21.17 $522,415 - $1.36 Million	-64,100 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$21.19 - $40.2 $1.36 Million - $2.58 Million	64,100 New	64,100 $1.37 Million

Others Institutions Holding NXTC

# of Institutions

Shares Held

13.7M

Call Options Held

1.7K

Put Options Held

View Full List

About NextCure, Inc.

Ticker NXTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,748,800
Market Cap $13.6M
Description
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...

More about NXTC

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account